The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process of negotiating prices for certain Medicare Part D drugs with input f | The agency said it is "considering opportunities to bring greater transparency" and will consider stakeholder feedback on the program.

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to help state Medicaid programs pay for expensive cell and gene therapy.

Federal agencies must stop disbursing financial assistance starting at 5 p.m. today under a new budget directive, threatening funding for providers and creating significant uncertainty for Medicaid payments to states.

State Medicaid programs across the country reported Tuesday they had lost access to federal payment portals one day after President Trump announced a freeze on federal grants and aid. By the late

Karoline Leavitt confirmed Tuesday afternoon the downed portals after multiple reports from lawmakers that their states could not get access to Medicaid dollars.

Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.

The Centers for Medicare & Medicaid Services on Friday released an informational bulletin with updated federal poverty level standards applied to eligibility criteria for Medicaid.

Given the prevalence of managed care, it’s incumbent upon the industry to ensure that there is a robust supplier pool.

House Democrats want to know what the Trump administration plans to do after it rescinded a Biden-era executive order to study potential payment models for lowering prescription drug costs,

Congress and Republican President Donald Trump have made it clear they intend to consider far-reaching policies to limit the scope of Medicaid in the name of slashing government spending.

Healthcare Management Solutions LLC can perform a $41 million auditing services task order for the Centers of Medicare and Medicaid Services despite the agency’s improper discussions, the US Court of Federal Claims said.